Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Genmab stock have an average target of 45.8, with a low estimate of 32 and a high estimate of 53. The average target predicts an increase of 83.94% from the current stock price of 24.90.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$32	$45.8	$48	$53
Change	+28.51%	+83.94%	+92.77%	+112.85%

Analyst Ratings

The average analyst rating for Genmab stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '24	Feb '24	Mar '24	Apr '24	May '24	Jun '24
Strong Buy	3	3	3	3	3	3
Buy	0	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	4	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+100.80%	Jun 27, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+100.80%	Jun 20, 2024
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $50 → $53	Strong Buy	Maintains	$50 → $53	+112.85%	Jun 4, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+100.80%	Jun 3, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50	Strong Buy	Reiterates	$50	+100.80%	May 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

20.27B

Increased by 23.05%

from 16.47B

Revenue Next Year

23.94B

Increased by 18.11%

from 20.27B

EPS This Year

83.22

Increased by 1,160.59%

from 6.60

EPS Next Year

108.59

Increased by 30.48%

from 83.22

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	5.37B	10.11B	8.42B	14.51B	16.47B	20.27B	23.94B	27.93B	33.35B	37.42B
Revenue Growth	77.39%	88.43%	-16.75%	72.33%	13.57%	23.05%	18.11%	16.63%	19.43%	12.21%
EPS	3.40	7.22	4.48	8.26	6.60	83.22	108.59	132.24	160.01	190.89
EPS Growth	43.40%	112.20%	-38.00%	84.48%	-20.06%	1,160.59%	30.48%	21.77%	21.00%	19.30%
Forward PE	-	-	-	-	-	0.30	0.23	0.19	0.16	0.13
No. Analysts	-	-	-	-	-	28	28	21	9	8

Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	21.3B	26.8B	32.2B	45.4B	51.9B
Avg	20.3B	23.9B	27.9B	33.4B	37.4B
Low	18.1B	21.3B	24.1B	28.5B	30.0B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	29.3%	32.3%	34.5%	62.5%	55.5%
Avg	23.1%	18.1%	16.6%	19.4%	12.2%
Low	9.9%	5.0%	0.7%	1.9%	-9.9%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	97.37	196.58	172.10	194.42	235.95
Avg	83.22	108.59	132.24	160.01	190.89
Low	69.38	81.18	92.57	137.66	163.85

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	1,374.8%	136.2%	58.5%	47.0%	47.5%
Avg	1,160.6%	30.5%	21.8%	21.0%	19.3%
Low	951.0%	-2.5%	-14.8%	4.1%	2.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.